Anti-endothelial cell antibodies in idiopathic and systemic sclerosis associated pulmonary arterial hypertension. - Wikidata - awgldk - TriplyDB

Anti-endothelial cell antibodies in idiopathic and systemic sclerosis associated pulmonary arterial hypertension.

Anti-endothelial cell antibodies in idiopathic and systemic sclerosis associated pulmonary arterial hypertension.

http://www.wikidata.org/entity/Q35537991

about

Immune and inflammatory mechanisms in pulmonary arterial hypertension Functional autoantibodies in systemic sclerosis pathogenesis.T lymphocyte subset abnormalities in the blood and lung in pulmonary arterial hypertension.Diagnosis and management of pulmonary hypertension in systemic sclerosis.Inflammation and immunity in the pathogenesis of pulmonary arterial hypertension Scleroderma lung disease Saudi Guidelines on the Diagnosis and Treatment of Pulmonary Hypertension: Pulmonary arterial hypertension associated with connective tissue diseases Increased regulatory and decreased CD8+ cytotoxic T cells in the blood of patients with idiopathic pulmonary arterial hypertension Pulmonary arterial hypertension associated with systemic sclerosis.Perivascular T-cell infiltration leads to sustained pulmonary artery remodeling after endothelial cell damage.Identification of target antigens of anti-endothelial cell and anti-vascular smooth muscle cell antibodies in patients with giant cell arteritis: a proteomic approach Associated pulmonary arterial hypertension in connective tissue diseases.Pulmonary arterial hypertension in connective tissue diseases.Antibodies recognising sulfated carbohydrates are prevalent in systemic sclerosis and associated with pulmonary vascular disease Peripheral blood B lymphocytes derived from patients with idiopathic pulmonary arterial hypertension express a different RNA pattern compared with healthy controls: a cross sectional study.Genetics and mediators in pulmonary arterial hypertension IgG from patients with systemic sclerosis bind to DNA antitopoisomerase 1 in normal human fibroblasts extracts.Bronchus-associated lymphoid tissue in pulmonary hypertension produces pathologic autoantibodies.Relevant issues in the pathology and pathobiology of pulmonary hypertension.New therapies for pulmonary arterial hypertension: an update on current bench to bedside translation.The role of inflammation and autoimmunity in the pathophysiology of pulmonary arterial hypertension.Inflammatory mechanisms in the pathogenesis of pulmonary arterial hypertension.Lung Circulation.Challenges and opportunities in treating inflammation associated with pulmonary hypertension.Epidemiology and treatment of pulmonary arterial hypertension.Update on novel targets and potential treatment avenues in pulmonary hypertension.Functional implications of IgG anti-endothelial cell antibodies in pulmonary arterial hypertension.[Pulmonary arterial hypertension: a flavor of autoimmunity].Role of cardiac inflammation in right ventricular failure.Immunoglobulin G anti-endothelial cell antibodies: inducers of endothelial cell apoptosis in pulmonary arterial hypertension?Immune cells and autoantibodies in pulmonary arterial hypertension.Pulmonary lymphoid neogenesis in idiopathic pulmonary arterial hypertension.Immune regulation of systemic hypertension, pulmonary arterial hypertension, and preeclampsia: shared disease mechanisms and translational opportunities.Anti-CENP-B and anti-TOPO-1-containing sera from systemic sclerosis-related diseases with Raynaud's phenomenon induce vascular endothelial cell senescence not via classical p53-p21 pathway.Inflammation and autoimmunity in pulmonary hypertension: is there a role for endothelial adhesion molecules? (2017 Grover Conference Series).Sex differences in pulmonary arterial hypertension: role of infection and autoimmunity in the pathogenesis of disease.Inflammation in Right Ventricular Failure: Does It Matter?

P2860

Q26851508-FF69BD9F-3E5E-4A1D-AAFB-E62122729B91 Q33360501-5F958CCE-FFA7-4EC2-95C7-A0118F2B6E6E Q33679052-8F5834A1-89D7-4E8B-A440-68BAAD027A02 Q33832379-2E970633-6393-4314-BFE5-616BF5A94AE4 Q33898213-301E12A2-4342-4D82-ADAA-434AB914C9B9 Q33919119-1618E7D2-1676-4E2B-A48F-3D876919183A Q33965825-6394FA94-4516-4897-88C7-4EDD7C4C2FE3 Q34536425-0A5B3A91-E0CA-4243-BCF0-DFD82A4DFCD5 Q35002423-2119258A-71F0-466E-A015-4C4BCDDDE8A2 Q35173533-13673130-D51B-46F6-8403-99DAD0D76B50 Q35557980-62ABEC5B-A420-43A7-985E-26EB26C23DD1 Q35617799-F8FFD52E-9F9E-49AE-95B2-1EB03EFF318B Q36075852-D5A49621-BE9D-4F5F-814A-F3501DF2F3AC Q36130814-0D8C403A-BEE2-4BC1-AD8C-B3F4B15EDC32 Q36487400-B7B5EA9F-6AC5-432C-9ABB-A6329DF7641D Q36752306-770C7A30-E1DD-49DA-A9D5-5FE8913EC085 Q37290678-15BECBC5-2489-461C-A0BE-8966176C24FE Q37393653-E19E61F4-C2DC-4867-8C9B-FF8160ACB83D Q37673917-EF1B347B-E080-4B2B-B64B-768D07589D74 Q37724192-369393DB-CFF7-4076-9B26-39723F876B29 Q37851851-61DCF470-E82D-4990-8E32-D320D0D64CF7 Q38111730-6A556A53-AB95-4AB1-BD18-B7A8615D4252 Q38804579-78FDCAFD-26B2-4CAC-B8EE-2E37DD4E9746 Q38812727-208AABF1-EF81-4A4F-AE30-725673F05E0F Q39359218-78125214-9491-44AC-8472-C2E0C7C3C41B Q42784219-C761FBD6-5870-4CED-882D-01DD636FED3F Q43538214-1491C84E-8A03-4755-80E6-F622A004E352 Q43717280-72F3E69C-B32A-4261-9E6A-210FEF8FE066 Q45068688-C66CEE13-162A-45BC-95C6-49E5DACEE263 Q46684209-0D067809-970B-467E-865C-2C39674F4523 Q47742357-A7C4F57D-0F10-48A6-A952-D5D4769898E6 Q49041508-37289F00-047B-421A-8900-0E2E43E0C7BC Q49600503-92965D67-1000-47A7-98F4-002679CB6951 Q49906728-B382DA6E-AF33-4B56-8214-C1B2895EA03B Q52685710-DFB94304-BCD5-416C-8FF5-DC9FC165DE03 Q54977617-A4327353-DC4C-4DFC-86B6-4D0F7ACCF998 Q58735426-E22CD5CA-25E4-41FB-9611-502FE392AF02

P2860

Anti-endothelial cell antibodies in idiopathic and systemic sclerosis associated pulmonary arterial hypertension.

http://www.wikidata.org/entity/Q35537991

description

2005 nî lūn-bûn

@nan

2005 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած

@hyw

2005 թվականի սեպտեմբերին հրատարակված գիտական հոդված

@hy

2005年の論文

@ja

2005年論文

@yue

2005年論文

@zh-hant

2005年論文

@zh-hk

2005年論文

@zh-mo

2005年論文

@zh-tw

2005年论文

@wuu

name

Anti-endothelial cell antibodi ...... lmonary arterial hypertension.

@ast

Anti-endothelial cell antibodi ...... lmonary arterial hypertension.

@en

type

label

Anti-endothelial cell antibodi ...... lmonary arterial hypertension.

@ast

Anti-endothelial cell antibodi ...... lmonary arterial hypertension.

@en

prefLabel

Anti-endothelial cell antibodi ...... lmonary arterial hypertension.

@ast

Anti-endothelial cell antibodi ...... lmonary arterial hypertension.

@en

P1433

Q35537991-13E7F842-6D06-4EB1-8A22-AA75C8803C0F

P1476

Q35537991-412BA002-5EBA-40EC-B2B9-49CD37F3AEAD

P2093

Q35537991-0312D23E-F182-4E1D-AC1A-BC819C6F03E0

Q35537991-24F1FE51-7ADC-4D4A-99EB-5ADFF34121D5

Q35537991-28AB17C6-0BDB-4F3F-81AE-BC048809D5B8

Q35537991-63991557-60DD-47B8-AD7C-917CFDFF60B0

Q35537991-6A8C6DB0-A41C-4222-BE1F-44830C60CA4D

Q35537991-6DA64529-E5F4-411B-A380-F26CAD396F64

Q35537991-89CEBA70-843D-4339-BCAE-22CE2186C082

Q35537991-901C8980-D440-426B-A7E3-8E514F04A681

Q35537991-9EF33507-1864-406B-A598-35C2245D698F

Q35537991-C3C3CA31-7ADF-4137-8231-AD10555AAABC

P2860

Q35537991-2A0C0115-3780-453F-91F5-42EC99260052

Q35537991-3C78F563-6334-4991-A95E-DCFE1760ED73

Q35537991-43FC0971-655F-4231-B60C-C2911629818E

Q35537991-44389DFC-B2FF-486F-AA37-20CCF6359364

Q35537991-49F56AA1-19F4-4BB4-AFE7-84BC948187C2

Q35537991-4A26621A-30B4-4856-83A1-FEBF3E38E9DA

Q35537991-5FD93187-5724-45CD-A03F-A8A8B9280F8F

Q35537991-6681A8BA-3BC1-41DF-9A07-1F0A766EA6DA

Q35537991-7E6A408D-1495-4C9B-989B-6B3A2BC6BC3D

Q35537991-861C5752-FBA2-4E75-A488-8D37F101995D

P304

Q35537991-8A52AEF6-A344-418A-AAD5-13842A4AEFCB

P31

Q35537991-2BB161FA-D279-4217-B8BB-9B3EC51D2023

P356

Q35537991-3568088F-0E95-4E76-8987-26EFDA53D0DC

P407

Q35537991-1217F2C8-7C08-4A5F-A13C-A704DC3397F7

P433

Q35537991-FAD2ACE9-20C1-4AA9-A1EE-D8F10F9C67C4

P478

Q35537991-C98E30CE-720E-4A2D-AEC6-937B2B81A51A

P577

Q35537991-26925577-12E7-4A0E-BD86-B3308AA15796

P5875

Q35537991-31443AFB-DF11-4565-B8D7-1F9CC0D07843

P698

Q35537991-CB968B23-28DD-4E19-8584-DE04ADA784A3

P921

Q35537991-96069CF6-57CE-40FB-9E37-0BE3D6BE4222

P932

Q35537991-4915AFD9-F767-4D94-B0E9-9C6A2B4A6A7C

P356

THX.2004.029082

P1433

P1476

Anti-endothelial cell antibodi ...... lmonary arterial hypertension.

@en

P2093

Boissier MC

http://www.w3.org/2001/XMLSchema#string

Brunet S

http://www.w3.org/2001/XMLSchema#string

Chanseaud Y

http://www.w3.org/2001/XMLSchema#string

Fermanian J

http://www.w3.org/2001/XMLSchema#string

Garcia-de-la-Peña-Lefebvre P

http://www.w3.org/2001/XMLSchema#string

Guillevin L

http://www.w3.org/2001/XMLSchema#string

Guilpain P

http://www.w3.org/2001/XMLSchema#string

Humbert M

http://www.w3.org/2001/XMLSchema#string

Mouthon L

http://www.w3.org/2001/XMLSchema#string

Servettaz A

http://www.w3.org/2001/XMLSchema#string

P2860

Human alpha-enolase from endothelial cells as a target antigen of anti-endothelial cell antibody in Behçet's disease

Proteomic study of human umbilical vein endothelial cells in culture

Clinical and molecular genetic features of pulmonary hypertension in patients with hereditary hemorrhagic telangiectasia.

Classification of anti-endothelial cell antibodies into antibodies against microvascular and macrovascular endothelial cells: the pathogenic and diagnostic implications.

Criteria for the classification of early systemic sclerosis.

Invariance and restriction toward a limited set of self-antigens characterize neonatal IgM antibody repertoires and prevail in autoreactive repertoires of healthy adults

Inflammation in pulmonary arterial hypertension.

Prevalence and outcome in systemic sclerosis associated pulmonary arterial hypertension: application of a registry approach.

Antiendothelial cell antibodies: useful markers of systemic sclerosis.

Antiendothelial cell antibodies in scleroderma correlate with severe digital ischemia and pulmonary arterial hypertension.

P304

765-772

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1136/THX.2004.029082

http://www.w3.org/2001/XMLSchema#string

P407

P433

9

http://www.w3.org/2001/XMLSchema#string

P478

60

http://www.w3.org/2001/XMLSchema#string

P577

2005-09-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

7624885

http://www.w3.org/2001/XMLSchema#string

P698

16135682

http://www.w3.org/2001/XMLSchema#string

P921

P932

1747530

http://www.w3.org/2001/XMLSchema#string